Mecasermin Completed Phase 2 Trials for Rett's Syndrome Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01777542Treatment of Rett Syndrome With Recombinant Human IGF-1